Schubert & CO Pacira Bio Sciences, Inc. Transaction History

Schubert & CO

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 02, 2023	BUY	$35.53 - $43.38 $106 - $130	3 Added 50.0%	9 $0
Q4 2022 Jan 31, 2023	SELL	$38.19 - $57.45 $152 - $229	-4 Reduced 40.0%	6 $0
Q3 2022 Oct 21, 2022	BUY	$51.24 - $58.89 $51 - $58	1 Added 11.11%	10 $1,000
Q2 2022 Aug 01, 2022	BUY	$51.49 - $81.64 $257 - $408	5 Added 125.0%	9 $1,000
Q1 2022 May 16, 2022	SELL	$60.03 - $76.49 $60 - $76	-1 Reduced 20.0%	4 $0
Q4 2021 Jan 28, 2022	BUY	$47.97 - $62.21 $239 - $311	5 New	5 $0

263

50.4M

429K

391K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $870M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Schubert & CO, based on Form 13F filings with the SEC.

Stay updated on Schubert & CO with notifications on news.